Strata Critical Medical, Inc.
NASDAQ Global MarketTotal Valuation
Strata Critical Medical, Inc. carries a market capitalization of 42,455.00, placing it among publicly traded companies globally. Its enterprise value stands at -15.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 42,455.00 |
| Enterprise Value | -15.40M |
Share Statistics
Strata Critical Medical, Inc. currently has 88.47M shares outstanding.
| Shares Outstanding | 88.47M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.03 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Financial Position
Strata Critical Medical, Inc. maintains a current ratio of 2.64, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.64 |
| Quick Ratio | 1.45 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | -1.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 16.01 |
| Return on Assets (ROA) | 13.62 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Strata Critical Medical, Inc.'s stock has declined approximately -99.74249% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.74249% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -4.12M, while operating income came in at -20.41M.
| Revenue | 255.98M |
| Gross Profit | 52.62M |
| Operating Income | -20.41M |
| Pretax Income | -23.16M |
| Net Income | 40.22M |
| EBITDA | -4.12M |
| EBIT | -20.41M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Strata Critical Medical, Inc. holds 22.75M in cash and equivalents against 4.26M in total debt, resulting in a net debt position of -16.32M. Total book value stands at 279.32M, with working capital of 75.23M providing operational flexibility.
| Cash & Cash Equivalents | 22.75M |
| Total Debt | 4.26M |
| Net Debt | -16.32M |
| Equity (Book Value) | 279.32M |
| Book Value Per Share | 3.16 |
| Working Capital | 75.23M |
Cash Flow
Strata Critical Medical, Inc. produced -36.03M in operating cash flow over the past twelve months.
| Operating Cash Flow | -36.03M |
| Capital Expenditures | -12.41M |
| Free Cash Flow | -48.45M |
| FCF Per Share | N/A |
Margins
Strata Critical Medical, Inc. operates with a gross margin of 20.56, reflecting its pricing power and cost economics. The operating margin of -7.97 and net profit margin of 15.71 provide insight into operational efficiency.
| Gross Margin | 20.56 |
| Operating Margin | -7.97 |
| Pretax Margin | -9.05 |
| Profit Margin | 15.71 |
| EBITDA Margin | -1.61 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 277.75 |
| FCF Yield | N/A |
Scores
Strata Critical Medical, Inc. posts an Altman Z-Score of 0.42, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.42 |